시장보고서
상품코드
1465922

세계의 TCR 요법 시장 보고서(2024년)

TCR Therapy Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

TCR 요법 시장 규모는 향후 수년간 비약적인 성장이 전망됩니다. 2028년에는 연간 평균 성장률(CAGR) 37.0%로 6억 5,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 진행 중인 임상시험의 급증, 헬스케어 분야의 혁신 기술 채택, 고형암에 대한 광범위한 적용, 규제 당국의 지원, 승인 절차 간소화, 보완 요법과의 통합 등 다양한 요인에 기인합니다. 이 기간 중 예상되는 세계 트렌드에는 고형암으로의 확장, 차세대 TCR 엔지니어링의 발전, 개인화 및 새로운 항원 식별 증가, 국제 공동 연구, 전략적 파트너십, 면역학 및 종양 생물학 분야의 진행 중인 연구 등이 포함됩니다.

암의 유병률 증가는 당분간 TCR 치료제 시장의 성장을 촉진할 것으로 예상됩니다. 암은 체내 비정상 세포의 억제되지 않은 증식과 확산을 특징으로 하는 질환으로, 건강한 조직을 침범하고 손상시켜 장기 기능과 전신 건강을 손상시킬 수 있으므로 심각한 위협이 되고 있습니다. 이 현상은 생활습관 선택, 고령화, 비만 확산, 유전적 소인 등에 기인하며, T세포 수용체(TCR) 치료는 암 치료제를 선택적으로 표적화하여 그 효과를 높이는 면역체계의 능력을 이용하는 것으로, 이 질병에 대처하는 획기적인 접근법이 될 수 있습니다. 예를 들어 영국의 의료 자선단체인 맥밀런 암 지원(Macmillan Cancer Support)은 2022년 10월, 암 환자 수가 2020년 300만 명으로부터 2025년에는 350만 명, 2030년에는 400만 명, 2040년에는 530만 명으로 증가할 것으로 예측하며 TCR 치료제 시장의 성장 동력을 강조하고 있습니다.

TCR 치료 분야의 주요 기업은 환자에게 필수적인 치료법을 제공하고 경쟁 우위를 확보하기 위해 전략적 파트너십 전략을 채택하고 있습니다. 전략적 파트너십은 서로의 강점과 자원을 활용하여 상호 이익과 성공을 추구하는 것입니다. 예를 들어 2023년 12월 미국 소재 바이오테크 기업 ImmunoScape는 싱가포르 제약사 EDDC(Experimental Drug Development Centre)와 고형암을 표적으로 하는 새로운 TCR 기반 이중특이성 분자 개발을 위해 파트너십을 체결했습니다. 제휴를 맺었습니다. 이번 협력은 ImmunoScape의 시스템 면역학 및 계산생물학 전문성과 EDDC의 역량을 활용하여 연구를 추진하고, 양사의 강점을 활용한 전략적 제휴를 통해 보다 접근성이 높고 효능이 높은 잠재적 암 치료제 개발을 촉진하는 것을 목표로 하고 있습니다.

목차

제1장 주요 요약

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

  • 세계의 TCR 요법 시장 촉진요인과 억제요인
    • 시장 촉진요인
    • 시장 억제요인
  • 세계의 TCR 요법 시장의 실적 : 규모와 성장, 2018-2023
  • 세계의 TCR 요법 시장 예측 : 규모와 성장, 2023-2028, 2033F

제6장 시장 세분화

  • 세계의 TCR 요법 시장 : 제품 유형별, 실적과 예측, 2018-2023, 2023-2028F, 2033F
  • 정맥주사
  • 주사제
  • 기타 제품 유형
  • 세계의 TCR 요법 시장 : 적응증별, 실적과 예측, 2018-2023, 2023-2028F, 2033F
  • 백혈병
  • 림프종
  • 골수종
  • 기타 적응증
  • 세계의 TCR 요법 시장 : 유통 채널별, 실적과 예측, 2018-2023, 2023-2028F, 2033F
  • 온라인
  • 오프라인
  • 세계의 TCR 요법 시장 : 최종사용자별, 실적과 예측, 2018-2023, 2023-2028F, 2033F
  • 병원 약국
  • 소매 약국
  • 전문 클리닉

제7장 지역별·국가별 분석

  • 세계의 TCR 요법 시장 : 지역별, 실적과 예측, 2018-2023, 2023-2028F, 2033F
  • 세계의 TCR 요법 시장 : 국가별, 실적과 예측, 2018-2023, 2023-2028F, 2033F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • TCR 요법 시장 : 경쟁 구도
  • TCR 요법 시장 : 기업 개요
    • Pfizer Inc.
    • Johnson & Johnson Services Inc.
    • Novartis AG
    • Bristol Myers Squibb Company
    • GlaxoSmithKline PLC

제31장 기타 대기업과 혁신적 기업

  • Gilead Sciences Inc.
  • Bluebird bio Inc.
  • Immunocore Limited
  • Immatics N.V.
  • Poseida Therapeutics Inc.
  • Fate Therapeutics Inc.
  • Atara Biotherapeutics Inc.
  • Intellia Therapeutics Inc.
  • Precision Biosciences Inc.
  • Takara Bio Inc.
  • Tessa Therapeutics
  • Adaptimmune Therapeutics plc
  • Cellectis S.A.
  • Zelluna Immunotherapy AS
  • Cellular Biomedicine Group Inc.

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 합병과 인수

제35장 전망과 잠재적 분석

제36장 부록

KSA 24.05.08

T-cell receptor (TCR) therapy is a type of immunotherapy that involves modifying a patient's T cells to enhance their ability to detect and combat cancer cells. Primarily utilized in cancer treatment, this therapy aims to leverage the body's immune system to target and eliminate cancerous cells.

TCR therapy encompasses various forms such as infusions, injectables, and other modalities. Infusions typically involve immersing a substance (e.g., herbs, tea leaves, or flavorings) in a liquid (usually hot water) to extract its properties or flavor. This therapy is utilized across multiple conditions including leukemia, lymphoma, myeloma, among others, and is accessible through both online and offline channels. Its end-users span hospital pharmacies, retail pharmacies, and specialty clinics.

The TCR therapy market research report is one of a series of new reports from The Business Research Company that provides TCR therapy market statistics, including TCR therapy industry global market size, regional shares, competitors with a TCR therapy market share, detailed TCR therapy market segments, market trends and opportunities, and any further data you may need to thrive in the TCR therapy industry. This TCR therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The TCR therapy market size has grown exponentially in recent years. It will grow from $0.13 billion in 2023 to $0.18 billion in 2024 at a compound annual growth rate (CAGR) of 40.6%. The growth observed during the historical period can be attributed to several factors, including a rise in cancer incidence, heightened interest in immunotherapy, promising outcomes from clinical trials, and substantial financial backing from investors.

The TCR therapy market size is expected to see exponential growth in the next few years. It will grow to $0.65 billion in 2028 at a compound annual growth rate (CAGR) of 37.0%. The anticipated growth in the forecast period is expected to stem from various factors, including a surge in ongoing clinical trials, the adoption of innovative technologies in healthcare, broader applications in solid tumors, regulatory backing, streamlined approval processes, and integration with complementary therapies. Significant trends projected for this period encompass the expansion into solid tumors, advancements in next-generation TCR engineering, a rise in personalization and neoantigen identification, global collaborations, strategic partnerships, and ongoing research in immunology and tumor biology.

The rising prevalence of cancer is anticipated to drive the expansion of the TCR therapy market in the foreseeable future. Cancer, a condition characterized by the unchecked proliferation and dissemination of abnormal cells in the body, poses a significant threat as it can infiltrate and damage healthy tissues, compromising organ function and systemic health. This phenomenon is attributed to lifestyle choices, the aging demographic, the widespread issue of obesity, and genetic predispositions. T-cell receptor (TCR) therapy exploits the immune system's capabilities to selectively target and enhance the efficacy of cancer treatment, offering a potentially revolutionary approach to addressing the disease. For example, Macmillan Cancer Support, a healthcare charity based in the UK, projected in October 2022 that the number of cancer cases would increase from 3 million in 2020 to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040, underscoring the driving force behind the growth of the TCR therapy market.

Leading players in the TCR therapy sector are embracing a strategic partnership strategy to deliver essential therapies to patients and gain a competitive advantage. Strategic partnerships involve leveraging each other's strengths and resources to achieve mutual benefits and success. For instance, in December 2023, ImmunoScape, a biotechnology company based in the US, collaborated with the Experimental Drug Development Centre (EDDC), a pharmaceutical company in Singapore, to develop novel TCR-based bispecific molecules targeting solid tumors. This collaboration aims to capitalize on ImmunoScape's expertise in systems immunology and computational biology, combined with EDDC's capabilities, to drive research forward and establish a strategic alliance that capitalizes on their respective strengths to expedite the development of more accessible and potentially more efficacious cancer treatments.

In January 2023, AstraZeneca, a pharmaceutical and biotechnology company headquartered in the UK, acquired Neogene Therapeutics Inc. for $320 million, significantly bolstering its presence in the burgeoning field of TCR-T therapy. This acquisition granted AstraZeneca access to cutting-edge technology, valuable expertise, and a shared commitment to advancing new cancer treatments, ultimately aiming to enhance the quality of life for patients across various cancer types. Neogene Therapeutics Inc., a US-based biotechnology company, is dedicated to developing next-generation, fully personalized engineered T-cell therapies for a wide range of cancers.

Major companies operating in the tcr therapy market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline PLC, Gilead Sciences Inc., Bluebird bio Inc., Immunocore Limited, Immatics N.V., Poseida Therapeutics Inc., Fate Therapeutics Inc., Atara Biotherapeutics Inc., Intellia Therapeutics Inc., Precision Biosciences Inc., Takara Bio Inc., Tessa Therapeutics, Adaptimmune Therapeutics plc, Cellectis S.A., Zelluna Immunotherapy AS, Cellular Biomedicine Group Inc., Lion TCR Pte Ltd, TCRCure Biopharma Corp., Asher Biotherapeutics Inc., Be Biopharma Inc., Alaunos Therapeutics Inc., China Immunotech Inc.

North America was the largest region in the TCR therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tcr therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tcr therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The TCR therapy market consists of revenues earned by entities by providing services such as genetic engineering services, quality control and assurance, clinical trial support, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The TCR therapy market also includes sales of TCR constructs, genetic modification tools, viral vectors, delivery systems, cell culture media and reagents, patient monitoring tools, and bioinformatics and data analysis tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

TCR Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on TCR therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for TCR therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The TCR therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product Type: Infusions; Injectables; Other Product Types
  • 2) By Indication: Leukemia; Lymphoma; Myeloma; Other Indication
  • 3) By Distribution Channel: Online; Offline
  • 4) By End-User: Hospital Pharmacy; Retail Pharmacy; Specialty Clinics
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Novartis AG; Bristol Myers Squibb Company; GlaxoSmithKline PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. TCR Therapy Market Characteristics

3. TCR Therapy Market Trends And Strategies

4. TCR Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global TCR Therapy Market Size and Growth

  • 5.1. Global TCR Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global TCR Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global TCR Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. TCR Therapy Market Segmentation

  • 6.1. Global TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infusions
  • Injectables
  • Other Product Types
  • 6.2. Global TCR Therapy Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Leukemia
  • Lymphoma
  • Myeloma
  • Other Indications
  • 6.3. Global TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Online
  • Offline
  • 6.4. Global TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Specialty Clinics

7. TCR Therapy Market Regional And Country Analysis

  • 7.1. Global TCR Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global TCR Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific TCR Therapy Market

  • 8.1. Asia-Pacific TCR Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China TCR Therapy Market

  • 9.1. China TCR Therapy Market Overview
  • 9.2. China TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India TCR Therapy Market

  • 10.1. India TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan TCR Therapy Market

  • 11.1. Japan TCR Therapy Market Overview
  • 11.2. Japan TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia TCR Therapy Market

  • 12.1. Australia TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia TCR Therapy Market

  • 13.1. Indonesia TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea TCR Therapy Market

  • 14.1. South Korea TCR Therapy Market Overview
  • 14.2. South Korea TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe TCR Therapy Market

  • 15.1. Western Europe TCR Therapy Market Overview
  • 15.2. Western Europe TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK TCR Therapy Market

  • 16.1. UK TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany TCR Therapy Market

  • 17.1. Germany TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France TCR Therapy Market

  • 18.1. France TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy TCR Therapy Market

  • 19.1. Italy TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain TCR Therapy Market

  • 20.1. Spain TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe TCR Therapy Market

  • 21.1. Eastern Europe TCR Therapy Market Overview
  • 21.2. Eastern Europe TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia TCR Therapy Market

  • 22.1. Russia TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America TCR Therapy Market

  • 23.1. North America TCR Therapy Market Overview
  • 23.2. North America TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA TCR Therapy Market

  • 24.1. USA TCR Therapy Market Overview
  • 24.2. USA TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada TCR Therapy Market

  • 25.1. Canada TCR Therapy Market Overview
  • 25.2. Canada TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America TCR Therapy Market

  • 26.1. South America TCR Therapy Market Overview
  • 26.2. South America TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil TCR Therapy Market

  • 27.1. Brazil TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East TCR Therapy Market

  • 28.1. Middle East TCR Therapy Market Overview
  • 28.2. Middle East TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa TCR Therapy Market

  • 29.1. Africa TCR Therapy Market Overview
  • 29.2. Africa TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. TCR Therapy Market Competitive Landscape And Company Profiles

  • 30.1. TCR Therapy Market Competitive Landscape
  • 30.2. TCR Therapy Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Novartis AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bristol Myers Squibb Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GlaxoSmithKline PLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. TCR Therapy Market Other Major And Innovative Companies

  • 31.1. Gilead Sciences Inc.
  • 31.2. Bluebird bio Inc.
  • 31.3. Immunocore Limited
  • 31.4. Immatics N.V.
  • 31.5. Poseida Therapeutics Inc.
  • 31.6. Fate Therapeutics Inc.
  • 31.7. Atara Biotherapeutics Inc.
  • 31.8. Intellia Therapeutics Inc.
  • 31.9. Precision Biosciences Inc.
  • 31.10. Takara Bio Inc.
  • 31.11. Tessa Therapeutics
  • 31.12. Adaptimmune Therapeutics plc
  • 31.13. Cellectis S.A.
  • 31.14. Zelluna Immunotherapy AS
  • 31.15. Cellular Biomedicine Group Inc.

32. Global TCR Therapy Market Competitive Benchmarking

33. Global TCR Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The TCR Therapy Market

35. TCR Therapy Market Future Outlook and Potential Analysis

  • 35.1 TCR Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 TCR Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 TCR Therapy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제